Compare INDRAPRASTHA MEDICAL with FORTIS HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL vs FORTIS HEALTHCARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDRAPRASTHA MEDICAL FORTIS HEALTHCARE INDRAPRASTHA MEDICAL/
FORTIS HEALTHCARE
 
P/E (TTM) x 17.6 39.3 44.7% View Chart
P/BV x 2.8 3.3 86.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 INDRAPRASTHA MEDICAL   FORTIS HEALTHCARE
EQUITY SHARE DATA
    INDRAPRASTHA MEDICAL
Mar-20
FORTIS HEALTHCARE
Mar-21
INDRAPRASTHA MEDICAL/
FORTIS HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs52217 24.2%   
Low Rs27113 24.2%   
Sales per share (Unadj.) Rs90.653.4 169.8%  
Earnings per share (Unadj.) Rs4.8-1.4 -346.4%  
Cash flow per share (Unadj.) Rs8.42.5 337.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs29.281.0 36.1%  
Shares outstanding (eoy) m91.67754.96 12.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.43.1 14.3%   
Avg P/E ratio x8.4-120.0 -7.0%  
P/CF ratio (eoy) x4.866.6 7.2%  
Price / Book Value ratio x1.42.0 67.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,660124,493 2.9%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1398,490 25.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,30840,301 20.6%  
Other income Rs m7466 1.5%   
Total revenues Rs m8,31540,767 20.4%   
Gross profit Rs m8644,057 21.3%  
Depreciation Rs m3302,906 11.3%   
Interest Rs m591,659 3.6%   
Profit before tax Rs m482-43 -1,130.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m46995 4.6%   
Profit after tax Rs m436-1,037 -42.1%  
Gross profit margin %10.410.1 103.3%  
Effective tax rate %9.5-2,333.2 -0.4%   
Net profit margin %5.3-2.6 -204.0%  
BALANCE SHEET DATA
Current assets Rs m1,41510,368 13.6%   
Current liabilities Rs m1,39612,330 11.3%   
Net working cap to sales %0.2-4.9 -4.6%  
Current ratio x1.00.8 120.5%  
Inventory Days Days271 3.0%  
Debtors Days Days35353 9.8%  
Net fixed assets Rs m3,07597,477 3.2%   
Share capital Rs m9177,550 12.1%   
"Free" reserves Rs m1,76153,629 3.3%   
Net worth Rs m2,67861,179 4.4%   
Long term debt Rs m09,677 0.0%   
Total assets Rs m4,490107,845 4.2%  
Interest coverage x9.11.0 938.6%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x1.90.4 495.1%   
Return on assets %11.00.6 1,914.5%  
Return on equity %16.3-1.7 -960.8%  
Return on capital %20.22.3 885.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,40821 6,705.8%   
Fx outflow Rs m34411 3,245.1%   
Net fx Rs m1,06410 10,233.0%   
CASH FLOW
From Operations Rs m8654,855 17.8%  
From Investments Rs m-402-1,351 29.8%  
From Financial Activity Rs m-427-1,429 29.9%  
Net Cashflow Rs m352,120 1.7%  

Share Holding

Indian Promoters % 49.4 0.0 -  
Foreign collaborators % 1.6 31.2 5.2%  
Indian inst/Mut Fund % 0.0 45.9 0.0%  
FIIs % 0.0 30.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 68.8 71.2%  
Shareholders   59,093 144,634 40.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDRAPRASTHA MEDICAL With:   TRANSGENE BI  SONI MEDICARE  MEDINOVA DIAG.  APOLLO HOSPITALS  SHALBY   



Today's Market

Indian Indices End Flat; Nestle, HDFC and ICICI Bank Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

FORTIS HEALTHCARE Announces Quarterly Results (1QFY22); Net Profit Up 321.3% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, FORTIS HEALTHCARE has posted a net profit of Rs 4 bn (up 321.3% YoY). Sales on the other hand came in at Rs 14 bn (up 132.7% YoY). Read on for a complete analysis of FORTIS HEALTHCARE's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

FORTIS HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Up 62.7% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, FORTIS HEALTHCARE has posted a net profit of Rs 735 m (up 62.7% YoY). Sales on the other hand came in at Rs 12 bn (up 6.0% YoY). Read on for a complete analysis of FORTIS HEALTHCARE's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

FORTIS HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Oct 18, 2019 | Updated on Oct 18, 2019

Here's an analysis of the annual report of FORTIS HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of FORTIS HEALTHCARE. Also includes updates on the valuation of FORTIS HEALTHCARE.

More Views on News

Most Popular

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

A Rare Buying Opportunity in an Exciting Stock(Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

How to Create a Second Income from Trading(Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

5 Indian Companies with Over 7% in Dividend Yield(Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDRAPRASTHA MEDICAL SHARE PRICE


Sep 22, 2021 (Close)

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL 5-YR ANALYSIS

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS